BiopharmaTrend.com

BioXcel Therapeutics

BioXcel Therapeutics

Public company
BIOXCEL THERAPEUTICS

BioXcel Therapeutics is a clinical stage biopharmaceutical company that utilizes novel artificial intelligence, or AI, to identify the next wave of medicines across neuroscience and immuno-oncology.


Founded
2017
Status
Public company
Geography
United States of America based
Funding
$69 M
Patents
7
Clinical Trials
6

Products

No products posted yet

Services

No services posted yet


This data is part of our proprietary analytics report:

This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality

Go to home page